메뉴 건너뛰기




Volumn 98, Issue 35, 2001, Pages 3658-3664

Vaccination offers good protection against measles, mumps and rubella;Vaccination mot mässling, påssjuka och röda hund har god skyddseffekt: Att avstå från att vaccinera skulle allvarligt hota vårt goda immunitetsläge

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

EID: 0035968493     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (17)
  • 1
    • 0002357553 scopus 로고    scopus 로고
    • Measles vaccine
    • Chapter 12. Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders Co
    • Redd SC, Markowitz LE, Katz SL. Measles vaccine. Chapter 12. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd edition. Philadelphia: WB Saunders Co; 1999: 222-66.
    • (1999) Vaccines. 3rd Edition , pp. 222-266
    • Redd, S.C.1    Markowitz, L.E.2    Katz, S.L.3
  • 2
    • 0002551986 scopus 로고    scopus 로고
    • Rubella vaccine
    • Chapter 17. Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders Co
    • Plotkin SA. Rubella vaccine. Chapter 17. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd edition, Philadelphia: WB Saunders Co; 1999: 409-39.
    • (1999) Vaccines. 3rd Edition , pp. 409-439
    • Plotkin, S.A.1
  • 3
    • 0001919802 scopus 로고    scopus 로고
    • Mumps vaccine
    • Chapter 13, Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders Co
    • Plotkin SA, Wharton M. Mumps vaccine. Chapter 13, In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd edition, Philadelphia: WB Saunders Co; 1999: 267-92.
    • (1999) Vaccines. 3rd Edition , pp. 267-292
    • Plotkin, S.A.1    Wharton, M.2
  • 4
    • 0032902266 scopus 로고    scopus 로고
    • Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children
    • Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. Pediatr Infect Dis J 1999;18:42-8.
    • (1999) Pediatr Infect Dis J , vol.18 , pp. 42-48
    • Usonis, V.1    Bakasenas, V.2    Kaufhold, A.3    Chitour, K.4    Clemens, R.5
  • 5
    • 0034603548 scopus 로고    scopus 로고
    • Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: A randomised trial
    • Dilray A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000;355:798-803.
    • (2000) Lancet , vol.355 , pp. 798-803
    • Dilray, A.1    Cutts, F.T.2    De Castro, J.F.3    Wheeler, J.G.4    Brown, D.5    Roth, C.6
  • 7
    • 0031808732 scopus 로고    scopus 로고
    • Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme
    • Broliden K, Levén B, Arneborn M, Böttiger M. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme. Scand J Infect Dis 1998;30:23-7.
    • (1998) Scand J Infect Dis , vol.30 , pp. 23-27
    • Broliden, K.1    Levén, B.2    Arneborn, M.3    Böttiger, M.4
  • 8
    • 0027977079 scopus 로고
    • Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults
    • Christenson B, Böttiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 1994;12:41-5.
    • (1994) Vaccine , vol.12 , pp. 41-45
    • Christenson, B.1    Böttiger, M.2
  • 9
    • 0029617269 scopus 로고
    • Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months
    • Böttiger M. Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months. Vaccine 1995;13:1759-62.
    • (1995) Vaccine , vol.13 , pp. 1759-1762
    • Böttiger, M.1
  • 10
    • 0031986114 scopus 로고    scopus 로고
    • Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme
    • Broliden K, Abreu ER, Arneborn M, Böttiger M. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Vaccine 1998;16:323-7.
    • (1998) Vaccine , vol.16 , pp. 323-327
    • Broliden, K.1    Abreu, E.R.2    Arneborn, M.3    Böttiger, M.4
  • 11
    • 0035825591 scopus 로고    scopus 로고
    • Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype
    • Nöjd J, Tecle T, Samuelsson A, Örvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001;19:1727-31.
    • (2001) Vaccine , vol.19 , pp. 1727-1731
    • Nöjd, J.1    Tecle, T.2    Samuelsson, A.3    Örvell, C.4
  • 12
    • 0033485608 scopus 로고    scopus 로고
    • Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity
    • Mossong J, Nokes DJ, Edmunds WJ, Cox MJ, Ratnam S, Muller CP. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol 1999; 150: 1238-49.
    • (1999) Am J Epidemiol , vol.150 , pp. 1238-1249
    • Mossong, J.1    Nokes, D.J.2    Edmunds, W.J.3    Cox, M.J.4    Ratnam, S.5    Muller, C.P.6
  • 13
    • 18144450017 scopus 로고
    • Litet antal biverkningar rapporterade efter vaccination mot mässling-påssjuka-röda hund
    • Taranger J, Wiholm BE. Litet antal biverkningar rapporterade efter vaccination mot mässling-påssjuka-röda hund. Läkartidningen 1987;84:948-50.
    • (1987) Läkartidningen , vol.84 , pp. 948-950
    • Taranger, J.1    Wiholm, B.E.2
  • 15
    • 0022577614 scopus 로고
    • Frequency of true adverse reactions to measles-mumps-rubella vaccine
    • Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine. Lancet 1986;i:939-42.
    • (1986) Lancet , vol.1 , pp. 939-942
    • Peltola, H.1    Heinonen, O.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.